
Amazon is in talks to purchase of podcast maker Wondery, a startup that could help the tech giant push more into the burgeoning podcast sector, The Wall Street Journal (WSJ) reported.
WSJ cited unnamed sources as saying the talks have valued Wondery at over US$300 million — a big increase from the podcast company’s value at its last funding round in June 2019, which priced the firm at about US$100 million.
WSJ reported Wondery is one of the last independent companies in the popular podcast market, potentially making it the final major option for a big tech company to buy into the field.
Wondery is known for true-crime podcasts like “Doctor Death,” “Dirty John” and “Over My Dead Body,” and it was the sixth-most-popular US podcast publisher in September, according to numbers from market watcher Podtrac, per WSJ.
Wondery attracted more than 60 million downloads and streams of its various shows in September, surpassed only by luminary names like NPR, iHeartMedia, and The New York Times, according to WSJ.
Wondery, along the lines of many contemporaries, has seen a boost from the general trend in podcasting in recent years, generating revenue from advertising fees as well as licensing fees and the optioning of rights to big media companies like AT&T and The Walt Disney Company, WSJ reported.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas